CDR-Life is a biopharmaceutical company that develops tumor targeted immunotherapies. The company has a uniquely powerful platform technology to target intracellular tumor antigens with highly potent and specific T cell engagers.
Products, services, technology
CDR-Life’s lead programs include novel immunotherapies targeting intracellular cancer-related proteins for superior tumor-selectivity and more durable efficacy. The company’s portfolio contains several first-in-class immunotherapies against solid and liquid tumors.
CDR-Life has a strategic partnership with a global pharmaceutical company and continues to partner with leading companies that share our vision of bringing highly innovative antibody therapies to patients.
Helping people live longer and better by bringing new cancer therapies that shrink tumors when nothing else works.
- A world class biotech team
- Developing breakthrough therapies
- Goal of helping people live longer and better